erythrosine has been researched along with ozagrel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikata, T; Morimoto, K; Tounai, T | 1 |
| Dillon, PK; Durán, WN | 1 |
| Ikata, T; Katoh, S; Mitsuhashi, T; Morimoto, K; Tonai, T | 1 |
3 other study(ies) available for erythrosine and ozagrel
| Article | Year |
|---|---|
[Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
Topics: 6-Ketoprostaglandin F1 alpha; Acrylates; Animals; Blood Vessels; Depression, Chemical; Fluoresceins; Male; Methacrylates; Rats; Rats, Inbred Strains; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries; Thromboxane B2; Thromboxane-A Synthase | 1990 |
Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation.
Topics: Animals; Benzofurans; Blood Pressure; Capillary Permeability; Cheek; Cricetinae; Dexamethasone; Dextrans; Dose-Response Relationship, Drug; Fluorescein-5-isothiocyanate; Fluoresceins; Hematocrit; Indomethacin; Lignans; Macromolecular Substances; Male; Mesocricetus; Methacrylates; Microcirculation; Platelet Activating Factor | 1988 |
Increased production of eicosanoids, TXA2, PGI2 and LTC4 in experimental spinal cord injuries.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Flavonoids; Fluoresceins; Guinea Pigs; Indomethacin; Leukotriene C4; Methacrylates; Radioimmunoassay; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries; Thromboxane A2; Thromboxane-A Synthase | 1994 |